CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionGross margin is 12%, lower than 95% of its Medical Instruments & Supplies peers (median 44.7%)
- FinancialsAltman Z-Score 1.71: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.68BCNY400.55M · vs all stocks (USD)
Revenue (TTM)
565.28MCNY84.41M · vs all stocks (USD)
Profit Margin
-18.85%vs Medical Instruments & Supplies peers
Beta
0.4270xvs all stocks
52-Week Change
57.82%vs all stocks
Market Capitalization
2.68BCNY400.55M · vs all stocks (USD)
Enterprise Value
2.95BCNY439.91M · vs all stocks (USD)
Price to Sales (TTM)
4.54xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
16.12xvs Medical Instruments & Supplies peers
Enterprise to Revenue
5.21xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-82.06xvs Medical Instruments & Supplies peers
Gross Margin
12.04%vs Medical Instruments & Supplies peers
Profit Margin
-18.85%vs Medical Instruments & Supplies peers
Operating Margin
-7.47%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-5.69%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-48.64%vs Medical Instruments & Supplies peers
Revenue (TTM)
565.28MCNY84.41M · vs all stocks (USD)
Revenue per Share (TTM)
1.92CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-14.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
11.76MCNY1.76M · vs all stocks (USD)
EBITDA (TTM)
-35.90MCNY-5.36M · vs all stocks (USD)
Net Income (TTM)
-106.53MCNY-15.91M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-32.28%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
16.11MCNY2.41M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
34.99MCNY5.23M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
3.98MCNYFY2025 · Dec 31, 2025Revenue
600.51MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
577.08MCNYFY2025 · Dec 31, 2025Gross Profit
23.43MCNYFY2025 · Dec 31, 2025Operating Income
-59.89MCNY-8.94M · vs all stocks (USD)
Pre-tax Income
-93.14MCNYFY2025 · Dec 31, 2025Income Tax Expense
7.97MCNYFY2025 · Dec 31, 2025Net Income
-101.12MCNYFY2025 · Dec 31, 2025EBIT
-71.41MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-5.92MCNYFY2025 · Dec 31, 2025Research & Development
28.61MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
19.37MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.09MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
62.70KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
21.73MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.3500CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.3500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
290.60MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
290.60MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-101.12MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-594.67KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-34.96MCNYFY2025 · Dec 31, 2025Free Cash Flow
-48.16MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
12.58MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-101.12MCNYFY2025 · Dec 31, 2025Other Non-cash Items
25.01MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-7.63MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
48.78MCNYFY2025 · Dec 31, 2025Capital Expenditures
-13.20MCNYFY2025 · Dec 31, 2025Net Acquisitions
-1.74MCNYFY2025 · Dec 31, 2025Sale of Investments
9.03MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-5.91MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
570.14MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-610.83MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-25.90MCNYFY2025 · Dec 31, 2025Other Financing Charges
-432.00KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-67.02MCNYFY2025 · Dec 31, 2025Shares Outstanding
289.04MSharesUpdated Sep 22, 2026Float Shares
136.41MSharesUpdated Sep 22, 2026% Held by Insiders
53.85%vs all stocks
% Held by Institutions
2.44%vs all stocks
Total Cash (MRQ)
57.95MCNY8.65M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.2000CNYUpdated Sep 22, 2026Total Debt (MRQ)
433.06MCNY64.67M · vs all stocks (USD)
Total Debt to Equity (MRQ)
2.65xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
0.4460xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
0.5510CNYUpdated Sep 22, 2026Total Assets
927.94MCNY138.57M · vs all stocks (USD)
Total Current Assets
322.00MCNYFY2025 · Dec 31, 2025Total Liabilities
746.77MCNYFY2025 · Dec 31, 2025Total Non-current Assets
605.94MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
83.39MCNYFY2025 · Dec 31, 2025Total Current Liabilities
663.38MCNYFY2025 · Dec 31, 2025Cash
12.58MCNYFY2025 · Dec 31, 2025Cash Equivalents
13.27MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
25.86MCNYFY2025 · Dec 31, 2025Other Short-term Investments
22.50MCNYFY2025 · Dec 31, 2025Accounts Receivable
114.99MCNYFY2025 · Dec 31, 2025Inventory
138.82MCNYFY2025 · Dec 31, 2025Accounts Payable
245.80MCNYFY2025 · Dec 31, 2025Short-term Debt
380.01MCNYFY2025 · Dec 31, 2025Other Current Liabilities
11.02MCNYFY2025 · Dec 31, 2025Long-term Debt
73.83MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
568.44KCNYFY2025 · Dec 31, 2025Common Stock (Book)
289.04MCNYFY2025 · Dec 31, 2025Retained Earnings
-259.94MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
181.17MCNY27.05M · vs all stocks (USD)
52-Week Low
5.30CNYUpdated Sep 22, 202652-Week High
10.39CNYUpdated Sep 22, 202652-Week Change
57.82%vs all stocks
Beta
0.4270xvs all stocks
50-Day MA
8.11CNYUpdated Sep 22, 2026200-Day MA
7.28CNYUpdated Sep 22, 2026Avg 10-Day Volume
10.70MSharesUpdated Sep 22, 2026Avg 30-Day Volume
13.67MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-0.3600CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 12%, lower than 95% of its Medical Instruments & Supplies peers (median 44.7%)Significant
Gross margin: 0.12Industry median: 0.45Industry P5: 0.18Peers compared: 62.00
Return on equity is -48.6%, lower than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: -0.49Industry median: 0.06Industry P5: -0.30Peers compared: 62.00
Current ratio is 0.45×, lower than 95% of its Medical Instruments & Supplies peers (median 2.2×)Significant
Current ratio: 0.45Industry median: 2.20Industry P5: 0.85Peers compared: 62.00
Debt-to-equity is 2.65×, higher than 95% of its Medical Instruments & Supplies peers (median 0.23×)Significant
Debt-to-equity: 2.65Industry median: 0.23Industry P95: 1.26Peers compared: 62.00
Price-to-book is 16.12×, higher than 95% of its Medical Instruments & Supplies peers (median 2.75×)Significant
Price-to-book: 16.12Industry median: 2.75Industry P95: 10.69Peers compared: 62.00
Financial Health
Altman Z-Score 1.71: grey zoneSignificant
Altman Z-Score: 1.71
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Seoul Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Wuxi Smart Auto-Control Engineering Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Kitazato Corporation
Tier 1ProductionThroughput-Bound ConversionRule
Deceuninck NV
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou Freely Communication Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ibstock plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Myriad Genetics Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shandong Gold Phoenix Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
RattanIndia Power Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shanghai Carthane Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Wuzhou Special Paper Group Co., Ltd.
1 interpretationElevated Leverage on Three Denominators
Sunwoda Electronic Co., Ltd.
1 interpretationElevated Leverage on Three Denominators
Wonders Information Co., Ltd.
1 interpretationElevated Leverage on Three Denominators